Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is
currently the most promising biomarker for early detection of ischemia before the onset of …

First identified in the early 1990s, IMA is produced when ischemia stresses released from
hypoxic heart tissue induce modification of circulating albumin. 5, 6 The amino terminal end …

OBJECTIVE--To study the outcome of pregnancy in women with artificial heart valves treated
in major European centres, and to compare the safety and efficacy of different anticoagulant …

Thromboembolism is an important complication of heart failure. To test the hypothesis that
heart failure may be associated with hemostatic dysfunction, we studied hemostatic function …

Objective: Promoting angiogenesis may be an effective treatment for patients with diffuse
peripheral vascular disease. This study investigated whether estrogen can promote …

Early diagnosis and treatment are pivotal for patients with acute aortic dissection (AAD). D-
dimer is a rule-out diagnostic test for pulmonary embolism but there is evidence that it may …

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a novel therapeutic option
for severe aortic stenosis in old patients with high surgical risk. The aim of this study was to …

Objectives: We examined whether ischemia-modified albumin (IMA) plasma levels change
during exercise stress testing (EST) in patients with known coronary artery disease and …

Objective: The authors investigated whether neutrophil to lymphocyte ratio (N/L) can
contribute to the diagnosis and risk assessment in patients with type A acute aortic …

Cardiovascular disease is the leading cause of death among women. Inflammation plays a
central role in the pathogenesis of many forms of vascular disease, including …